Jim Cramer Breaks Silence On DeepSeek AI Sell-Off & Discusses These 12 Stocks

Page 2 of 11

10. Abbott Laboratories (NYSE:ABT)

Number of Hedge Fund Holders In Q3 2024: 63

Abbott Laboratories (NYSE:ABT) is a global healthcare giant whose medical device business is driving its narrative. The firm’s glucose monitors have helped it navigate a tumultuous 2024 where it struggled from a slowdown in China and an infant formula lawsuit. Abbott Laboratories (NYSE:ABT) glucose monitors have left Cramer impressed as he believes that the market is underappreciating the firm’s potential to make an impact in the diabetes market. In his latest remarks, Cramer wondered how much hot money was in Abbott Laboratories (NYSE:ABT) stock at a time when tech was crashing:

“Well look at Abbott Labs then. Oh my god. Are you serious? Was there that much hot money in that?”

Page 2 of 11